Download PDF
Schlaf 2013; 2(04): 249-250
DOI: 10.1055/s-0038-1626074
PHARMAKOTHERAPIE IN DER PRAXIS
Schattauer GmbH

Antidepressivum Mirtazapin

Auswirkungen auf das RLS und periodische Beinbewegungen im Schlaf
Mina C. Hinsch
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie Albert-Schweitzer-Camp. 1 48149 Münster Tel. 0251/8356601, Email: minacarolina.hinsch@ukmuenster.de
› Author Affiliations
Further Information

Publication History

Publication Date:
10 February 2018 (online)

    Permissions and Reprints

 

 

  • Literatur

  • 1 Chopra A, Pendergrass DS, Bostwick JM. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS. Psychosomatics 2011; 52 (01) 92-94.
    CrossrefPubMedGoogle Scholar
  • 2 Hoque R, Chesson Jr. AL. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010; 6 (01) 79-83.
    PubMedGoogle Scholar
  • 3 Fulda S, Kloiber S, Dose T. et al. Mirtazapine Provokes Periodic Leg Movements during Sleep in Young Healthy Men. Sleep 2013; 36 (05) 661-669.
    CrossrefPubMedGoogle Scholar
  • 4 Kim SW, Shin IS, Kim JM. et al. Factors potentiating the risk of mirtazapine-associated restless legs syndrome. Hum Psychopharmacol 2008; 23 (07) 615-620.
    CrossrefPubMedGoogle Scholar
  • 5 Park YM, Lee HJ, Kang SG. et al. Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder. Psychiatry Investig 2009; 6 (04) 313-315.
    CrossrefPubMedGoogle Scholar
  • 5a Rottach KG, Schaner BM, Kirch MH. et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008; 43 (01) 70-75.
    CrossrefPubMedGoogle Scholar
  • 6 Teive HA, de Quadros A, Barros FC, Werneck LC. [Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report]. Arq Neuropsiquiatr 2002; 60 (04) 1025-1029.
    CrossrefPubMedGoogle Scholar